Antineoplastic

PHRMA says that 860 of antineoplastic drugs are under the clinical experimental stage. This number is double time of heart disease and apoplexy sum total, aids and other infectious diseases sum total. Meanwhile, it is also the double time of total Alzheimer's disease and other nervous system disease. The global antitumor drug’s marketing total turnover breaks through 60 billion USD, and becomes the biggest sort of all the drugs.

Tumor is not a single disease, and it is combined of tens of diseases and even of hundreds of diseases. It is valued of praise that antineoplastic drugs are cline to two developing trends. One is the newest science development has provided the antineoplastic drugs researchers a new target, the other is drug pharmacy companies discovered that high value of antineoplastic drugs bring them irresistible profits.

To BELTROAD, what we are searching for is to make more profit to the less part of people rather than making less profit to much more people.